Congestive Heart Failure (CHF) Treatment Devices Market is expected to grow at a CAGR of 5.5% during the forecast period. Congestive Heart Failure (CHF) Treatment Devices Market is expected to reach US$ 5.16 Mn. by 2029.Congestive Heart Failure (CHF) Treatment Devices Market Overview:
Congestive heart failure (CHF) is a disorder in which the heart muscles' capacity to pump enough blood is impaired. Shortness of breath, exhaustion, and leg swelling are all symptoms of this illness. As a result, it's critical to control heart failure with the help of numerous devices available on the market, such as defibrillators and pacemakers.To know about the Research Methodology :- Request Free Sample Report
Congestive Heart Failure (CHF) Treatment Devices Market Dynamics:
Rising prevalence of cardiac disorders is the major factor contributing to the market growth. The failure of the ventricles to pump a sufficient volume of blood to the bodily organs marks the beginnings of CHF. This causes fluid to accumulate in the lungs, abdomen, liver, and lower body. Pacemakers, cardiac resynchronization treatment (CRT), implanted cardioverter defibrillators (ICDs), and ventricular assist devices are among the technologies used to treat CHF. The growing frequency of cardiovascular disorders, technological improvements, and the rising number of cardiovascular surgeries are driving the market for congestive heart failure (CHF) therapy devices. Other important factors linked to the development of CVDs include sedentary lifestyles, junk food consumption, and mental stress. According to the World Health Organization, cardiovascular disease is the leading cause of death worldwide in 2019, claiming the lives of an estimated 17.9 million people each year. As a result, the large target group has a positive impact on the treatment of congestive heart failure. Globally, the growing geriatric population is leading to an increase in CVD cases. To increase market share, market players are focused on new growth strategies such as product launches, developments, mergers, and acquisitions. For example, Abbott Laboratories' HeartMate 3 Left Ventricular Assist Device (LVAD) was approved by the US Food and Drug Administration (FDA) in October 2018 for the treatment of heart failure. In developing markets, there is likely to be a large unmet treatment need for congestive heart failure. High equipment costs and unfavourable reimbursement rules are two concerns that could stymie the congestive heart failure treatment market's revenue growth. The report has profiled sixteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Congestive Heart Failure (CHF) Treatment Devices Market Segment Analysis:
The Congestive Heart Failure (CHF) Treatment Devices Market is segmented on the basis of Product and End-Users. Based on Product, the Implantable pacemakers segment is expected to account for significant market share xx% by 2029. An implantable pacemaker is a device that regulates cardiac rhythm using electrical impulses. An internal pacemaker has electrodes that are implanted in the heart and electronic circuitry and a power supply that is inserted within the body. According to a study published in the Journal of Arrhythmia in July 2020 by Ana C Gonzales-Luna et al., the COVID-19 pandemic resulted in a 73% reduction in pacemaker implants and a 78% reduction in de-novo pacemaker implants in patients diagnosed with complete or high-grade atrioventricular block, regardless of the aetiology. The growth of the implantable pacemakers segment is being fuelled by an increase in cardiovascular patients, as well as an increase in the geriatric population, reimbursement coverage, and technological advancements such as exclusive algorithms that accurately detect and reduce the risk of atrial fibrillation. The Implantable Cardioverter Defibrillators segment is expected to grow at a significant CAGR of xx% throughout the forecast period. Implantable Cardioverter Defibrillators (ICDs) have a sizable market share thanks to their capacity to perform three main functions: defibrillation, cardioversion, and cardiac pacing. In 2019, the ICD category, which is divided into two types: transvenous and subcutaneous, had a sizable market share.Congestive Heart Failure (CHF) Treatment Devices Market Regional Insights:
North America is expected to dominate the market during forecast years. Increased demand for congestive heart failure (CHF) therapy, rising prevalence of target illnesses, high healthcare spending, and increased population awareness about treatment device availability are some of the reasons driving market growth in the North American area. COVID-19 individuals with an underlying heart problem are still more likely to become critically unwell, according to the Centres for Disease Control and Prevention (CDC). In addition, supportive illness awareness activities are expected to assist the market for cardiovascular devices in the North American area. Mexico, for example, joined the HEARTS project in 2020 to improve primary health care for cardiovascular illnesses. As a result of the aforementioned factors, the market in North America is likely to rise at a rapid pace over the forecast years. The report also helps in understanding Global Congestive Heart Failure (CHF) Treatment Devices Market dynamics, structure by analyzing the market segments and project the Global Congestive Heart Failure (CHF) Treatment Devices Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Congestive Heart Failure (CHF) Treatment Devices Market make the report investor’s guide.Congestive Heart Failure (CHF) Treatment Devices Market, Key Development:
• Teleflex Inc. acquired the acquisition of Z-Medica LLC, a prominent maker of hemostatic products, in February 2021. • Abbott Laboratories announced in December 2020 that the United States Food and Drug Administration (FDA) had authorised amended labelling for its HeartMate 3 heart pump for use in young patients with advanced refractory left ventricular heart failure.Congestive Heart Failure (CHF) Treatment Devices Market Scope: Inquire before buying
Congestive Heart Failure (CHF) Treatment Devices Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 3.55 Mn. Forecast Period 2023 to 2029 CAGR: 5.5% Market Size in 2029: US $ 5.16 Mn. Segments Covered: by Product • Ventricular Assist Devices • LVAD • RVAD • BiVAD • Counter Pulsation Device • Implantable Cardioverter Defibrillators • Transvenous ICD • Subcutaneous ICD • Pacemakers • Implantable • External by End-Users • Hospitals • Ambulatory Care Centers • Others Congestive Heart Failure (CHF) Treatment Devices Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Congestive Heart Failure (CHF) Treatment Devices Market, Key players:
• Boston Scientific Corporation • Medtronic PLC • Abiomed, Inc. • HeartWare International, Inc. • Jarvik Heart, Inc. • LivaNova PLC • ReliantHeart Inc. • Biotronik SE & Co., KG • St. Jude Medical • Berlin Heart GmbH • Teleflex, Inc. • Abbott • Edwards Lifesciences Corporation • Johnson & Johnson Services, Inc • MicroPort Scientific Corporation • Mayo Foundation Frequently Asked Questions: 1. Which region has the largest share in Global Congestive Heart Failure (CHF) Treatment Devices Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Congestive Heart Failure (CHF) Treatment Devices Market? Ans: The Global Congestive Heart Failure (CHF) Treatment Devices Market is growing at a CAGR of 5.5% during forecasting period 2023-2029. 3. What is scope of the Global Congestive Heart Failure (CHF) Treatment Devices Market report? Ans: Global Congestive Heart Failure (CHF) Treatment Devices Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Congestive Heart Failure (CHF) Treatment Devices Market? Ans: The important key players in the Global Congestive Heart Failure (CHF) Treatment Devices Market are – Boston Scientific Corporation, Medtronic PLC, Abiomed, Inc., HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, ReliantHeart Inc., Biotronik SE & Co., KG, St. Jude Medical, Berlin Heart GmbH, Teleflex, Inc., Abbott, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc, MicroPort Scientific Corporation, and Mayo Foundation 5. What is the study period of this Market? Ans: The Global Congestive Heart Failure (CHF) Treatment Devices Market is studied from 2022 to 2029.
- 1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Congestive Heart Failure (CHF) Treatment Devices Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Congestive Heart Failure (CHF) Treatment Devices Market 3.4. Geographical Snapshot of the Congestive Heart Failure (CHF) Treatment Devices Market, By Manufacturer share 4. Global Congestive Heart Failure (CHF) Treatment Devices Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Congestive Heart Failure (CHF) Treatment Devices Market 5. Supply Side and Demand Side Indicators 6. Global Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecast, 2022-2029 6.1. Global Congestive Heart Failure (CHF) Treatment Devices Market Size & Y-o-Y Growth Analysis. 7. Global Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 7.1.1. Ventricular Assist Devices 7.1.1.1. LVAD 7.1.1.2. RVAD 7.1.1.3. BiVAD 7.1.2. Counter Pulsation Devices 7.1.3. Implantable Cardioverter Defibrillators 7.1.3.1. Transvenous ICD 7.1.3.2. Subcutaneous ICD 7.1.4. Pacemakers 7.1.4.1. Implantable 7.1.4.2. External 7.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 7.2.1. Hospitals 7.2.2. Ambulatory Care Centers 7.2.3. Others 8. Global Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 9.1.1. Ventricular Assist Devices 9.1.1.1. LVAD 9.1.1.2. RVAD 9.1.1.3. BiVAD 9.1.2. Counter Pulsation Devices 9.1.3. Implantable Cardioverter Defibrillators 9.1.3.1. Transvenous ICD 9.1.3.2. Subcutaneous ICD 9.1.4. Pacemakers 9.1.4.1. Implantable 9.1.4.2. External 9.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 9.2.1. Hospitals 9.2.2. Ambulatory Care Centers 9.2.3. Others 10. North America Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 12. Canada Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 13. Mexico Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 14. Europe Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 15. Europe Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 17. France Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 18. Germany Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 19. Italy Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 20. Spain Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 21. Sweden Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 22. CIS Countries Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 23. Rest of Europe Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 24. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 25. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 27. India Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 28. Japan Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 29. South Korea Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 30. Australia Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 31. ASEAN Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 32. Rest of Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 33. Middle East Africa Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 34. Middle East Africa Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 36. GCC Countries Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 37. Egypt Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 38. Nigeria Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 39. Rest of ME&A Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 40. South America Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 41. South America Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 43. Argentina Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 44. Rest of South America Congestive Heart Failure (CHF) Treatment Devices Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Congestive Heart Failure (CHF) Treatment Devices Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Boston Scientific Corporation 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Medtronic PLC 45.3.3. Abiomed, Inc. 45.3.4. HeartWare International, Inc. 45.3.5. Jarvik Heart, Inc. 45.3.6. LivaNova PLC 45.3.7. ReliantHeart Inc. 45.3.8. Biotronik SE & Co., KG 45.3.9. St. Jude Medical 45.3.10. Berlin Heart GmbH 45.3.11. Teleflex, Inc. 45.3.12. Abbott 45.3.13. Edwards Lifesciences Corporation 45.3.14. Johnson & Johnson Services, Inc 45.3.15. MicroPort Scientific Corporation 45.3.16. Mayo Foundation 46. Primary Key Insights